Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|1|3|244-254

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.1, Iss.3, 2008-11, pp. : 244-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1387-1398

Bentham Science Publishers

Access to resources Recommend Favorite

Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1804-1820

Bentham Science Publishers

Access to resources Recommend Favorite

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 699-707

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogenes as Novel Targets for Cancer Therapy (Part IV): Regulators of the Cell Cycle and Apoptosis

By Zhang Zhuo   Li Mao   Rayburn Elizabeth R.   Hill Donald L.   Zhang Ruiwen   Wang Hui  

American Journal of PharmacoGenomics, Vol. 5, Iss. 6, 2005-01 ,pp. : 397-407

Adis International

Access to resources Recommend Favorite